Chad Riggs

Working in Technology Transfer, Marketing, Communications; and Commercialization and Start-Up Consulting

[Chad Riggs @lynnisjr]

Happy @AUTM technology transfer professionals day #ttpd #bayhdoleact thanks @StJude legal and @StJudeResearch legal!

[Chad Riggs @lynnisjr]

Today #AUTM celebrates technology transfer professionals. December 12 is the anniversary of the Bayh-Dole Act of 1980, which enabled #technologytransfer through #universities retaining title to #inventions that can become #patented and #licensed #innovations. #IAmTechTransfer

[Chad Riggs @lynnisjr]

I know it is an election year, but I think we should all agree that it is way overdue to get way out-of -line Pharmacy Benefit Managers in-line (CVS Caremark, Express Scripts, OptumRx, etc.)
FTC to take action against PBMs, groups urge reforms https://t.co/SMjgLdPgX1

[Chad Riggs @lynnisjr]

@RealMattCouch NO. But after means testing, yes

[Chad Riggs @lynnisjr]

@TechnologyAvai1 @StJudeResearch translated to millions outside of campus

[Chad Riggs @lynnisjr]

December 12, 2023 is Technology Transfer Professionals Day, the 43rd anniversary of the signing of the Bayh-Dole Act, enabling Technology Transfer!
(Celebrating in Memphis,TN @5pm at Flip Side Memphis and @6:45pm at Crosstown Brewing, RSVP to [email protected])

[Chad Riggs @lynnisjr]

The Office of Technology Licensing offers subscription communications for St. Jude innovators, technology licensing, researchers, and tech transfer news and gatherings. All this can be yours by subscribing.

Subscribe | St. Jude Research (https://t.co/5D6N5ZetqM)

[Chad Riggs @lynnisjr]

What caused the inflation.

Well, actually? Amazon.

Thank you government for going after them.

https://t.co/iEho7JZwAA

[Chad Riggs @lynnisjr]

@choose901 Only the LAME ones... more of a St. Louis thing.

[Chad Riggs @lynnisjr]

Lynnis R. is in cub scouts Pack 13, and they sell popcorn. It is overpriced, but think of it as a donation and your “free gift” is popcorn if it helps?
No obligation, just letting you know.
https://t.co/oSsZsx8aBb
Lynnis’s Scout KeyCode is: J6HX

Thanks!

[Chad Riggs @lynnisjr]

Members can be from any institution, but large numbers have been from St. Jude Children’s Research Hospital, UTHSC, University of Memphis, and many graduate students from all over the country working in Memphis labs.

[Chad Riggs @lynnisjr]

The Mid-South Academic Alliance will hold more lectures and networking events as “MemBioBreaks,” to sign up for updates, please go to the form on this page: https://t.co/ru63ApuHID and enter your information with the box you select.

[Chad Riggs @lynnisjr]

Founded in 2013, it has been a great resource through the years for working or networking opportunities, and having a good time at other events like the upcoming LifeScienceTN Beer & Biotech, LSTCON, the Scipreneur Challenge, etc.

[Chad Riggs @lynnisjr]

Because these neo-splice sites (or the cryptic exons) are not used in normal cells, therapies targeting these sites are expected to be nontoxic to normal cells and theoretically have an infinite therapeutic window.

[Chad Riggs @lynnisjr]

We are seeking a partner to develop DNA Sequences Unique to Cancer cells and take it to market. https://t.co/VxG6jpVZKx

[Chad Riggs @lynnisjr]

This genome-editing- and etiology-based strategy for cancer therapy includes an algorithm for identifying cryptic exons arising from aberrant splicing unique to cancer cells and can be applied to fusion-positive cancer patients with neo-splicing that introduced cryptic exons.

[Chad Riggs @lynnisjr]

BUY BUY BUY!
Cub Scout Popcorn Sale: Lynnis Riggs | Pack 13 https://t.co/oSsZsx8aBb

[Technology Available for License @TechnologyAvai1]

Combination DNMT3a KO and IL10 signaling (SJ-21-0018) (https://t.co/3K5qbbUgss) preserves the cell’s multipotent state during manufacturing and persistence and is available for license! More publications: DOI: 10.1126/scitranslmed.abh0272

[Technology Available for License @TechnologyAvai1]

NEW Publication! Method to Activate Fetal Hemoglobin Expression (SJ-20-0020) (https://t.co/3K5qbbUgss) manipulates HSCs from sickle cell disease or β-thalassemia patients to induce fetal hemoglobin and is available to license! https://t.co/8CsFUlNSQV

[Technology Available for License @TechnologyAvai1]

NEW Publication! Promoter Modification to Reduce AAV Contamination (SJ-19-0003 (https://t.co/3K5qbbUgss) has a published patent application and 2022 and 23 publications listing many advantages and is available to license!

[Chad Riggs @lynnisjr]

@TechnologyAvai1 https://t.co/n9rtjgnn3H